![](/img/cover-not-exists.png)
PCN142 COST-EFFECTIVENESS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA IN BELGIUM: ANALYSIS USING 48-MONTH OVERALL SURVIVAL FROM CHECKMATE 067
Baker, T., Paly, V.F., Johnson, H.M., Van Campenhout, H., Amadi, A., Chandran, N., Moshyk, A., Kotapati, S.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.338
Date:
November, 2019
File:
PDF, 650 KB
english, 2019